Completed
Efficacy and Safety of Xepol (Human Immunoglobulin) in Subjects With Post-Polio Syndrome (PPS)
NCT00160082
- Conditions
- Central Nervous System Diseases, Central Nervous System Infections, Enterovirus Infections, +17 more
- Locations
-
- Danderyd Hospital Danderyd, Sweden
- Sahlgrenska University Hospital Gothenburg, Sweden
- Huddinge University Hospital Stockholm, Sweden
- Uppsala Academic Hospital Uppsala, Sweden